Indolent Small Intestinal CD4+ T-cell Lymphoma Is a Distinct Entity with Unique Biologic and Clinical Features

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Margolskee, Elizabeth ^a   Jobanputra, Vaidehi ^a   Lewis, Suzanne K ^a   Alobeid, Bachir ^a   Green, Peter H R ^a   Bhagat, Govind ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD7 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELIAC DISEASE; DEATH; DIARRHEA; DISEASE COURSE; DOWN REGULATION; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; GENE REARRANGEMENT; GENOMIC INSTABILITY; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INTESTINE BIOPSY; INTESTINE PERFORATION; INTESTINE VILLUS ATROPHY; LAMINA PROPRIA; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LYMPHOMA; T CELL RECEPTOR BETA GENE; WEIGHT REDUCTION;

ADULT; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; INTESTINE, SMALL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANTIGEN, T-CELL; WEIGHT LOSS;

EID: 84879813445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068343     Document Type: Article

References (53)

1. Isaacson PG, Du MQ, (2005) Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol 205: 255-274.
2. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M, (2003) Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97: 2462-2473.
3. Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ, (1993) Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 17: 429-442.
4. Kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, et al. (2003) Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 43: 135-143.
5. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L, (1980) Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 46: 215-222.
6. Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, et al. (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113: 3931-3937.
7. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, et al. (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118: 148-155.
8. Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, et al. (2011) Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol 35: 1557-1569.
9. Burke JS, (2011) Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis. Arch Pathol Lab Med 135: 1283-1297.
10. Lavergne A, Brocheriou I, Delfau MH, Copie-Bergman C, Houdart R, et al. (1998) Primary intestinal gamma-delta T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology 32: 271-276.
11. Carey MJ, Medeiros LJ, Roepke JE, Kjeldsberg CR, Elenitoba-Johnson KS, (1999) Primary anaplastic large cell lymphoma of the small intestine. Am J Clin Pathol 112: 696-701.
12. Ranheim EA, Jones C, Zehnder JL, Warnke R, Yuen A, (2000) Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am J Surg Pathol 24: 296-301.
13. Egawa N, Fukayama M, Kawaguchi K, Hishima T, Hayashi Y, et al. (1995) Relapsing oral and colonic ulcers with monoclonal T-cell infiltration. A low grade mucosal T-lymphoproliferative disease of the digestive tract. Cancer 75: 1728-1733.
14. Carbonnel F, d'Almagne H, Lavergne A, Matuchansky C, Brouet JC, et al. (1999) The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut 45: 662-667.
15. Carbonnel F, Lavergne A, Messing B, Tsapis A, Berger R, et al. (1994) Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation. Cancer 73: 1286-1291.
16. Zivny J, Banner BF, Agrawal S, Pihan G, Barnard GF, (2004) CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue. Dig Dis Sci 49: 551-555.
17. Svrcek M, Garderet L, Sebbagh V, Rosenzwajg M, Parc Y, et al. (2007) Small intestinal CD4+ T-cell lymphoma: a rare distinctive clinicopathological entity associated with prolonged survival. Virchows Arch 451: 1091-1093.
18. Hirakawa K, Fuchigami T, Nakamura S, Daimaru Y, Ohshima K, et al. (1996) Primary gastrointestinal T-cell lymphoma resembling multiple lymphomatous polyposis. Gastroenterology 111: 778-782.
19. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, et al. (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117: 1447-1452.
20. Isaacson PG CA, Ott G, et al. (2008) Enteropathy-associated T-cell lymphoma. In: Swerdlow SH CE HN, et al., editor. WHO classification of Tumours of the Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC. 289-291.
21. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317.
22. Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, et al. (1987) A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 17: 1279-1285.
23. Tse E, Gill H, Loong F, Kim SJ, Ng SB, et al. (2012) Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol 87: 663-668.
24. Chott A, Haedicke W, Mosberger I, Fodinger M, Winkler K, et al. (1998) Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153: 1483-1490.
25. Shevach EM, (2006) From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25: 195-201.
26. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM, (2000) T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr Opin Cell Biol 12: 563-568.
27. Beier UH, Akimova T, Liu Y, Wang L, Hancock WW, (2011) Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. Curr Opin Immunol 23: 670-678.
28. van Loosdregt J, Brunen D, Fleskens V, Pals CE, Lam EW, et al. (2011) Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 6: e19047.
29. van Loosdregt J, Vercoulen Y, Guichelaar T, Gent YY, Beekman JM, et al. (2010) Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115: 965-974.
30. Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, Mollejo M, Garcia JF, et al. (2009) Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33: 81-90.
31. Cannons JL, Lu KT, Schwartzberg PL, (2013) T follicular helper cell diversity and plasticity. Trends Immunol 34: 200-207.
32. Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, et al. (2009) Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom 76: 367-374.
33. Verkarre V, Asnafi V, Lecomte T, Patey Mariaud-de Serre N, Leborgne M, et al. (2003) Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 52: 205-211.
34. Malamut G, Chandesris O, Verkarre V, Meresse B, Callens C, et al. (2013) Enteropathy associated T cell lymphoma in celiac disease: A large retrospective study. Dig Liver Dis 45: 377-384.
35. Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136: 81-90.
36. Kaneki T, Kawashima A, Akamatsu T, Tanaka N, Kubo K, et al. (1999) Immunoblastic lymphadenopathy-like T-cell lymphoma complicated by multiple gastrointestinal involvement. J Gastroenterol 34: 253-259.
37. Moreb J, Okon E, Matzner Y, Polliack A, (1983) Angioimmunoblastic lymphadenopathy. A case with an unusual clinical course with marked tumorous infiltration of multiple organs and striking intestinal involvement. Cancer 51: 487-491.
38. Toyota S, Nakamura N, Dan K, (2002) T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal involvement and a new chromosomal abnormality. Int J Hematol 75: 314-317.
39. Velagapudi P, Turagam M, Uzoaru I, Graham D, (2011) Small bowel obstruction due to mycosis fungoides: an unusual presentation. Am J Med Sci 341: 508-509.
40. Slater DN, Bleehen SS, Beck S, (1984) Gastrointestinal complications of mycosis fungoides. J R Soc Med 77: 114-119.
41. Tokunaga O, Watanabe T, Shimamoto Y, Tokudome S, (1993) Primary T-cell lymphoma of the gastrointestinal tract associated with human T-cell lymphotropic virus type I. An analysis using in situ hybridization and polymerase chain reaction. Cancer 71: 708-716.
42. Green PH, Cellier C, (2007) Celiac disease. N Engl J Med 357: 1731-1743.
43. Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, et al. (1997) Autoimmune enteropathy and villous atrophy in adults. Lancet 350: 106-109.
44. Sharaiha RZ, Lebwohl B, Reimers L, Bhagat G, Green PH, et al. (2012) Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer 118: 3786-3792.
45. Laabi Y, Gras MP, Carbonnel F, Brouet JC, Berger R, et al. (1992) A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J 11: 3897-3904.
46. Rickert RC, Jellusova J, Miletic AV, (2011) Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 244: 115-133.
47. Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, et al. (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132: 1902-1911.
48. Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, et al. (2002) Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 161: 1635-1645.
49. Baumgartner AK, Zettl A, Chott A, Ott G, Muller-Hermelink HK, et al. (2003) High frequency of genetic aberrations in enteropathy-type T-cell lymphoma. Lab Invest 83: 1509-1516.
50. Mitchell TJ, John S, (2005) Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 114: 301-312.
51. Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, et al. (2007) Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 129: 345-357.
52. Harel S, Tu EY, Weisberg S, Esquilin M, Chambers SM, et al. (2012) ZFX controls the self-renewal of human embryonic stem cells. PLoS One 7: e42302.
53. Nikpour P, Emadi-Baygi M, Mohammad-Hashem F, Maracy MR, Haghjooy-Javanmard S, (2012) Differential expression of ZFX gene in gastric cancer. J Biosci 37: 85-90.